Research Article
Effect of Entecavir Combined with Adefovir Dipivoxil on Clinical Efficacy and TNF-α and IL-6 Levels in Patients with Hepatitis B Cirrhosis
Table 1
Comparison of general information between the two groups (
n (%),
).
| Group | Experimental group | Control group | X2/t | |
| Gender (male/female) | 23/27 | 26/24 | 0.36 | 0.55 | Age (years old) | 43.39 ± 6.21 | 43.77 ± 6.39 | 0.30 | 0.76 | Height (cm) | 165.32 ± 10.01 | 165.64 ± 10.37 | 0.16 | 0.88 | Weight (kg) | 71.45 ± 5.90 | 71.39 ± 5.64 | 0.05 | 0.96 | Disease course (months) | 5.68 ± 1.69 | 5.72 ± 1.73 | 0.12 | 0.91 | Smoking history (years) | 4.31 ± 1.33 | 4.27 ± 1.38 | 0.15 | 0.88 | Drinking history (years) | 10.96 ± 1.38 | 10.52 ± 1.22 | 1.69 | 0.09 | Hypertension (cases) | 13 | 15 | 0.20 | 0.66 | Diabetes (cases) | 8 | 7 | 0.08 | 0.78 | Hyperlipidemia (cases) | 4 | 6 | 0.44 | 0.51 |
|
|